ADT Use for Prostate Cancer Linked to Increased Risk for CVD Death
FRIDAY, July 29, 2022 (HealthDay News) — For patients with prostate cancer, use of androgen-deprivation therapy (ADT) is associated with an increased risk for cardiovascular disease (CVD) death, according to a study published online July 26 in The Ag…
Learn MoreGreater Abdominal Aortic Calcification Ups Dementia Risk in Older Women
FRIDAY, July 29, 2022 (HealthDay News) — Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 in The Lancet Regional Health: Western Pacific.
…
Learn MoreHormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
FRIDAY, July 29, 2022 (HealthDay News) — In postmenopausal women treated for early-stage estrogen receptor-positive breast cancer, neither vaginal estrogen therapy (VET) nor menopausal hormone therapy (MHT) is associated with an increased risk for …
Learn MoreKids With ADHD Have Differences in ‘Neural Flexibility,’ Brain Study Shows
FRIDAY, July 29, 2022 (HealthDay News) — Children with ADHD may have less flexibility in the brain circuitry that allows for seamless “multitasking,” a new study suggests.Research has shown that kids with attention deficit hyperactivity disorder ofte…
Learn MoreE-Cigarette Use Tied to Future Cannabis Use in Teens
FRIDAY, July 29, 2022 (HealthDay News) — There is a strong individual-level association between adolescent electronic cigarette use and subsequent cannabis use, according to a study published online July 22 in JAMA Network Open.
Ruoyan Sun, Ph.D….
Learn MoreSeizures in Young Stroke Survivors Double Dementia Risk
FRIDAY, July 29, 2022 (HealthDay News) — The onset of seizures in young stroke survivors is associated with more than a doubled risk for developing dementia, according to a study published July 26 in Neurology.
Alain Lekoubou, M.D., from Penn Sta…
Learn MoreEffect of Noradrenergic Drugs Explored in Alzheimer Disease
FRIDAY, July 29, 2022 (HealthDay News) — Noradrenergic drugs seem to have a positive effect for general cognition and apathy in Alzheimer disease, according to a review published online July 5 in the Journal of Neurology, Neurosurgery & Psychiatry….
Learn MoreGenetic Alterations ID’d in Many Pediatric Solid Tumors
FRIDAY, July 29, 2022 (HealthDay News) — Clinically significant genetic variations are identified in 86 percent of solid tumors in pediatric patients, according to a study published online June 23 in Nature Medicine.
Alanna J. Church, M.D., from …
Learn MoreTheophylline Nasal Irrigation Studied in COVID-19-Related Smell Loss
FRIDAY, July 29, 2022 (HealthDay News) — For patients with COVID-19-related olfactory dysfunction (OD), the clinical benefit of theophylline added to saline nasal irrigation (SNI) is inconclusive, according to a study published online July 7 in JAMA …
Learn MoreCOVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
FRIDAY, July 29, 2022 (HealthDay News) — For patients with hematologic malignancy without seroconversion after initial COVID-19 vaccination, seroconversion often occurs after booster vaccination, according to a study published online July 11 in Can…
Learn More